Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Publishing timestamp: 2024-06-24 17:59:05
Summary
Novo Nordisk is investing $4.1 billion to build a new manufacturing plant in North Carolina to increase supply of its weight loss drug Wegovy and diabetes treatment Ozempic. The company plans to invest $6.8 billion in production this year and expects the new facility to be completed between 2027 and 2029.
Sentiment: NEUTRAL
Keywords: business, eli lilly and co, pharmaceuticals, health care industry, biotechnology, business news, biotech and pharmaceuticals, novo nordisk a/s, united states,
Source: https://www.cnbc.com/2024/06/24/novo-nordisk-nc-facility-wegovy-ozempic-output.html